De Nigris E - Search Results

1

Healthcare resource utilization and costs of chronic lymphocytic leukemia/small lymphocytic lymphoma patients who relapse or are refractory to ibrutinib.

De Nigris E, Yang X, Zanardo E, Lejeune D, Farooqui MZ, Gandra SR, Laliberté F. De Nigris E, et al. Future Oncol. 2024;20(35):2723-2735. doi: 10.1080/14796694.2024.2390351. Epub 2024 Oct 7. Future Oncol. 2024. PMID: 39373600 Free PMC article.

2

Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study.

Huntington SF, Cheng WY, Sarpong EM, Leng S, Farooqui MZH, Agu US, Catillon M, Lejeune D, Downes N, Matay L, Duh MS, De Nigris E. Huntington SF, et al. Among authors: de nigris e. Leuk Lymphoma. 2024 Jul;65(7):932-942. doi: 10.1080/10428194.2024.2331631. Epub 2024 May 2. Leuk Lymphoma. 2024. PMID: 38696747

3

Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia.

Huntington SF, de Nigris E, Puckett JT, Kamal-Bahl S, Farooqui M, Ryland K, Sarpong EM, Leng S, Yang X, Doshi JA. Huntington SF, et al. Among authors: de nigris e. Cancer Med. 2024 Jan;13(2):e6953. doi: 10.1002/cam4.6953. Cancer Med. 2024. PMID: 38348963 Free PMC article.

4

Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the US.

Yang X, Zanardo E, Lejeune D, De Nigris E, Sarpong E, Farooqui M, Laliberté F. Yang X, et al. Among authors: de nigris e. Oncologist. 2024 Mar 4;29(3):e360-e371. doi: 10.1093/oncolo/oyad324. Oncologist. 2024. PMID: 38280190 Free PMC article.

5

Associations between the EQ-5D-5L and exacerbations of chronic obstructive pulmonary disease in the ETHOS trial.

Jackson D, Jenkins M, de Nigris E, Purkayastha D, Patel M, Ouwens M. Jackson D, et al. Among authors: de nigris e. Qual Life Res. 2024 Apr;33(4):1029-1039. doi: 10.1007/s11136-023-03582-z. Epub 2024 Jan 11. Qual Life Res. 2024. PMID: 38206455 Free PMC article.

6

Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia.

Huntington SF, de Nigris E, Puckett J, Kamal-Bahl S, Farooqui M, Ryland K, Sarpong E, Leng S, Yang X, Doshi JA. Huntington SF, et al. Among authors: de nigris e. Leuk Lymphoma. 2023 Dec;64(14):2286-2295. doi: 10.1080/10428194.2023.2256911. Epub 2023 Dec 25. Leuk Lymphoma. 2023. PMID: 37870435

7

Short- and Long-Term Impact of Prior Chronic Obstructive Pulmonary Disease Exacerbations on Healthcare Resource Utilization and Related Costs: An Observational Study (SHERLOCK).

de Nigris E, Haughney J, Lee AJ, Nath M, Müllerová H, Holmgren U, Ding B. de Nigris E, et al. COPD. 2023 Dec;20(1):92-100. doi: 10.1080/15412555.2022.2136065. Epub 2023 Jan 19. COPD. 2023. PMID: 36656661 Free article.

8

Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study.

de Nigris E, Treharne C, Brighton N, Holmgren U, Walker A, Haughney J. de Nigris E, et al. Int J Chron Obstruct Pulmon Dis. 2022 Nov 22;17:2987-3000. doi: 10.2147/COPD.S381138. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36444374 Free PMC article.

9

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study.

Whittaker H, Nordon C, Rubino A, Morris T, Xu Y, De Nigris E, Müllerová H, Quint JK. Whittaker H, et al. Among authors: de nigris e. Thorax. 2023 Aug;78(8):760-766. doi: 10.1136/thorax-2022-219039. Epub 2022 Oct 31. Thorax. 2023. PMID: 36316117 Free PMC article.

10

Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.

Hurst JR, Han MK, Singh B, Sharma S, Kaur G, de Nigris E, Holmgren U, Siddiqui MK. Hurst JR, et al. Among authors: de nigris e. Respir Res. 2022 Aug 23;23(1):213. doi: 10.1186/s12931-022-02123-5. Respir Res. 2022. PMID: 35999538 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters